Cita APA (7a ed.)
Ueno, M., Takeda, H., Takai, A., Morimura, H., Nishijima, N., Iwamoto, S., . . . Takahashi, K. (2024). Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study. Journal of Gastroenterology, 59(12), 1119-1120.
Cita Chicago Style (17a ed.)
Ueno, Masayuki, et al. "Publisher Correction: CRAFITY Score as a Predictive Marker for Refractoriness to Atezolizumab Plus Bevacizumab Therapy in Hepatocellular Carcinoma: A Multicenter Retrospective Study." Journal of Gastroenterology 59, no. 12 (2024): 1119-1120.
Cita MLA (9a ed.)
Ueno, Masayuki, et al. "Publisher Correction: CRAFITY Score as a Predictive Marker for Refractoriness to Atezolizumab Plus Bevacizumab Therapy in Hepatocellular Carcinoma: A Multicenter Retrospective Study." Journal of Gastroenterology, vol. 59, no. 12, 2024, pp. 1119-1120.
Precaución: Estas citas no son 100% exactas.